Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV: A Comparison of Reduced-dose Prasugrel and Clopidogrel in Elderly Patients With Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention (PCI)

NCT01777503 is registered in ClinicalTrials.gov with Azienda USL Reggio Emilia - IRCCS as lead sponsor.

NCT NCT01777503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01777503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV: A Comparison of Reduced-dose Prasugrel and Clopidogrel in Elderly Patients With Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention (PCI)
Lead sponsor
Azienda USL Reggio Emilia - IRCCS
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2012
Completion date
December 19, 2017
Enrollment
1,457 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, cardiovascular diseases, coronary arteriosclerosis, myocardial ischemia